
April 11, 2024
RegMed Investors’ (RMi) pre-open: a double whammy of market and sector arithmetic
April 10, 2024
RegMed Investors (RMi) Closing Bell: the cell and gene therapy sector got chewed-up, bloods everywhere
April 10, 2024
RegMed Investors’ (RMi) pre-open: another little progress against inflation report?
April 9, 2024
RegMed Investors’ (RMi) pre-open: WHAT and WHEN are the catalysts to move share pricing
April 8, 2024
RegMed Investors (RMi) Closing Bell: what’s moving the sector?
April 8, 2024
RegMed Investors’ (RMi) pre-open: expectation versus circumstances
April 5, 2024
RegMed Investors (RMi) Closing Bell: economic circumstances drove a 5 session/weekly downside
April 5, 2024
RegMed Investors’ (RMi) pre-open: The sector remains highly sensitive in any indication
April 4, 2024
RegMed Investors (RMi) Closing Bell: economics undermine sector’s share pricing before jobs report
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors